This conference aims at discussing the state of the art of computational methods as effective tools
for drug discovery. Toward this end, we have integrated topics that are, and will remain, central to
the field, such as structure-based drug discovery and molecular modeling and simulations for drug
design, with the introduction of novel aspects that are nowadays among the hot topics in the field of
drug discovery, such as binding kinetics, and methods for target identification/validation.
S p e a k e r s
Prof. R. Abagyan (UC San Diego, USA)
Prof. P. Carloni (INM9/IAS-5, Jülich GmbH, DE)
Dr. G. Colombo (Istituto di Chimica, CNR, IT)
Dr. Z. Cournia (Academy of Athens, GR)
Prof. R. Levy (Temple University, USA)
Dr. J. Mason (Heptares Therapeutics, UK)
Prof. O. Michielin (UniL, CH)
Prof. A. Mulholland (Bristol University, UK)
Prof. G. Cruciani (University of Perugia, IT)
Dr. A. Pan (DE Shaw Research, USA)
Dr. M.D. Cummings (Janssen USA)
Prof. M. Parrinello (ETH Zurich, CH)
Dr. E. Duffy (Melinta Therapeutics, USA)
Prof. W. L. Jorgensen (Yale University, USA)
Prof. G. Klebe (Philipps-Universität Marburg, DE)
Prof. L. Scapozza (Université de Genève, CH)
Dr. W. Sherman (Schrodinger Inc., USA)
Prof. R. Walker (UC San Diego, USA)
O r g a n i z i n g
C o m m i t t e e
Prof. Andrea Cavalli Prof. Matteo Dal Peraro
University of Bologna and IIT, Italy EPF Lausanne, Switzerland
Prof. Kenneth M. Merz Jr. Dr. Marco De Vivo
Michigan State University, USA Istituto Italiano di Tecnologia, Italy
h t t p : / / s b d d 2 0 1 5 . e p f l . c h